Mr. Marcos Agramont reports

ISODIOL INTERNATIONAL INC. ANNOUNCES EXTENSION OF LICENSING AGREEMENT WITH KATHY IRELAND AND LEVEL BRANDS

Isodiol International Inc. has signed an amendment to the licence agreement with Level Brands Inc. The amended agreement extends the terms from five years to 10 years and expands the territorial coverage from North America to worldwide. The amendment was entered into after both parties concluded discussions contemplated under the terms of the agreement.

Marcos Agramont, chief executive officer of Isodiol, said: "Upon further discussion with Kathy Ireland and the Level Brands team, it became clear that both sides share a common goal, which is to help people around the globe understand how cannabidiol is beneficial for the human body. With this expanded agreement, we will now be able to introduce a variety of Isodiol brands to Kathy's extremely large network around the globe. Over all, Level Brands is innovative in licensing, marketing and brand management, and this will further assist Isodiol in providing consistent and highly bioactive products. The opportunity to increase this partnership from North America to worldwide is something that we believe will have a tremendous impact on Isodiol in the short and long term."

Kathy Ireland, chairman emeritus and chief brand strategist of Level Brands, said: "Our vision is that Isodiol will become the leading CBD company in the world. The CBD market is at its infancy, and we believe, based on our research and decades of brand building, that the CBD industry will see enormous growth over the next decade on a worldwide basis. We look forward to working with the Isodiol team to execute on a multifaceted marketing strategy that we feel will enable Isodiol to grow its bulk and private label businesses, as well be able to rapidly go to market with specialized branded lines of unique and best-in-class products."

The Isodiol product portfolio will include body balms, tinctures, personal care, nano-mist and functional beverages.

Martin Sumichrast, chairman and chief executive officer of Level Brands, also added: "We believe that the technology that the Isodiol team has acquired and is acquiring will allow Isodiol to be at the forefront of the CBD industry. Our companies have embarked on a decade-long partnership which has the potential to not only sell consumer branded products worldwide, but also bring to market new innovative means I believe will provide consumers the benefits of CBD. We are incredibly grateful for this opportunity and the leadership that Kathy and the team at kathy ireland worldwide has and will provide to Level Brands and the team at Isodiol."

No additional consideration was issued for the expanded territorial coverage from North America to worldwide.

About Isodiol International Inc.

Isodiol International is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products. Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99 per cent plus pure, bioactive pharmaceutical grade cannabinoids, microencapsulations, and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio, and aggressively continuing international expansion into Latin America, Asia and Europe.

We seek Safe Harbor.